Humana Inc. (NYSE:HUM) Shares Bought by Virtu Financial LLC

Virtu Financial LLC boosted its position in shares of Humana Inc. (NYSE:HUM) by 85.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,699 shares of the insurance provider’s stock after buying an additional 1,706 shares during the period. Virtu Financial LLC’s holdings in Humana were worth $938,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in HUM. Landscape Capital Management L.L.C. increased its position in Humana by 54.4% during the third quarter. Landscape Capital Management L.L.C. now owns 2,451 shares of the insurance provider’s stock worth $776,000 after buying an additional 864 shares during the period. Massachusetts Financial Services Co. MA increased its position in Humana by 42.0% during the third quarter. Massachusetts Financial Services Co. MA now owns 391,657 shares of the insurance provider’s stock worth $124,053,000 after buying an additional 115,820 shares during the period. Meridian Wealth Management LLC acquired a new position in Humana during the third quarter worth approximately $1,072,000. Cerity Partners LLC increased its position in Humana by 72.0% during the third quarter. Cerity Partners LLC now owns 31,605 shares of the insurance provider’s stock worth $10,011,000 after buying an additional 13,233 shares during the period. Finally, Swedbank AB increased its position in Humana by 3.0% during the third quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock worth $33,567,000 after buying an additional 3,085 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 0.37% of the company’s stock.

Analyst Ratings Changes

HUM has been the topic of several analyst reports. Royal Bank of Canada reiterated an “outperform” rating and issued a $283.00 target price on shares of Humana in a research note on Wednesday, February 12th. Piper Sandler lifted their target price on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday, January 15th. StockNews.com downgraded Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, March 18th. Truist Financial lifted their target price on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Finally, Morgan Stanley lowered their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 12th. Eighteen research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $285.68.

Humana Stock Performance

Shares of HUM stock opened at $266.33 on Monday. The stock has a fifty day moving average price of $271.33 and a 200 day moving average price of $276.25. The stock has a market cap of $32.14 billion, a PE ratio of 26.77, a P/E/G ratio of 2.05 and a beta of 0.57. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.33%. Humana’s dividend payout ratio (DPR) is 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.